SecurPharm is the common initiative of the associations of drug manufacturers, wholesalers, and pharmacists designed to develop technical solutions to comply with the requirements of the EU Directive on combating counterfeiting.
At the meeting on 30 March 2012, the participants involved in the project agreed on essential technical and organisational details to be implemented in the pilot project. This project will start in the beginning of 2013 in Germany.
Among the decisions taken, it has been agreed that
Dr Stephan Schwarze, Bayer Pharma AG, will present the newest developments of SecurPharm at the Conference "Strategies against Counterfeit / Falsified Medicines" taking place from 7 - 8 May 2012 in Würzburg, Germany.
Author:
Dr Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)